Current market catalysts

Morgan Stanley Upgrades Flagstar Bank to Overweight, Raises Price Target to $17

Morgan Stanley Upgrades East West Bancorp to Overweight, Raises Price Target to $160

Morgan Stanley Downgrades Customers Bancorp to Underweight, Raises Price Target to $89

ABM Isn’t Just Cleaning Buildings Anymore — Its Data Center Pipeline Is Multiplying

ABM stock jumps 7% after beating Q3 2026 earnings estimates, boosted by semiconductor and data center growth. Read the snapshot.

Morgan Stanley Upgrades Cullen/Frost Bankers to Overweight, Raises Price Target to $200

Morgan Stanley Upgrades Commerce Bancshares to Overweight, Raises Price Target to $76

Morgan Stanley Downgrades Central Bancompany to Equal-Weight, Raises Price Target to $36

Morgan Stanley Downgrades Bank OZK to Underweight, Maintains Price Target to $56

Watching Taiwan Semiconductor Manufacturing; Hearing Investor Business Daily SwingTrader Buys Stock

Morgan Stanley Initiates Coverage On PDF Solutions with Overweight Rating, Announces Price Target of $62

Morgan Stanley Upgrades Synopsys to Overweight, Maintains Price Target to $500

8-K filing — Federal Home Loan Bank of Dallas

Filed: 2026-09-08 AccNo: 0001331757-26-000163 Size: 204 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K filing — Healthcare Triangle, Inc. (HCTI)

Filed: 2026-09-08 AccNo: 0001213900-26-097953 Size: 606 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Morgan Stanley Upgrades M&T Bank to Overweight, Raises Price Target to $304

Why Is Lumentum Stock Surging on Tuesday?

Lumentum Holdings Inc (NASDAQ: LITE) stock gains Tuesday following a major optical fiber supply deal between Corning and Verizon Communications.

Morgan Stanley Downgrades Peloton Interactive to Underweight, Lowers Price Target to $4.5

Does Michael Burry Have It Wrong? Nvidia Chips Retain Value, Data Shows

Nvidia’s 6-year-old A100 chips still carry nearly $5,000 in estimated value, challenging Michael Burry’s AI depreciation warning.

HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

Sarepta Therapeutics shares react to Novartis Phase 3 trial results in DM1 while Sarepta progresses its SRP-1003 RNA therapy clinical trials.

Piper Sandler Maintains Overweight on Equity Bancshares, Raises Price Target to $60

Why Oracle Stock is the Trade to Watch After OpenAI's AGI Claim

Oracle's $300 billion OpenAI deal makes it an AGI infrastructure proxy. Thursday's earnings will test cloud growth and backlog conversion.

Piper Sandler Reiterates Overweight on Shopify, Raises Price Target to $180

Why Is Cipher Digital Stock Surging on Tuesday?

Cipher Digital Inc (NASDAQ: CIFR) stock is trading higher Tuesday after announcing lateral pipeline developments for high-performance computing data centers.

Stifel Maintains Buy on Hinge Health, Raises Price Target to $115

B. Riley Securities Maintains Neutral on eGain, Lowers Price Target to $6

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.

HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target

U.S. Cyber, Law Enforcement Officials Accuse Chinese AI Companies Of 'Aggressive, Industrial-Scale Distillation Activities'

United Natural Foods Plans for More Inflation in 2027, Says Productivity, Not Price Hikes, Will Drive Margins

United Natural Foods (UNFI) beats Q4 EPS estimates and issues strong FY2027 guidance. Read the full earnings and stock performance report.

Tenable Integrates Anthropic’s Claude Mythos 5 Into Tenable One For AI-Powered Exposure Management